As well, circulating soluble CD40L levels were elevated in first episode unmedicated MDD patients and these levels were reduced when antidepressant interventions were administered (Leo et al., 2006; Myung et al., 2016), though another study reported reduced CD40L serum levels in MDD patients (Zhang et al., 2023). This evidence concerns the gene CD40LG and major depressive disorder.